Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — 4QFY21 Earnings Presentation
17 slides from Sunshine's earnings presentation, May 28, 2021
Slide 1: Earnings Presentation 4QFY21
Earnings Presentation 4QFY21 28th May 2021
Slide 2: Group Performance
Group Performance
Slide 3: Group at a Glance – 4QFY21
Group at a Glance – 4QFY21 Including Akbar Pharmaceuticals (Pvt) Ltd from February 2021 and Daintee Limited results from September 2021 • LKR 6.9bn in Revenue; +37.1% YoY ; • LKR 650m PAT; +387.9%YoY ; • PATMI of LKR 397m; Revenue - 4QFY20 Other, 1% • Healthcare revenue; LKR 3.7bn; +24.0% YoY Consum
Slide 4: Group Financial Highlights
Group Financial Highlights Growth LKR m FY21 FY20 % 4Q FY21 4Q FY20 Growth % Revenue 24,339 20,875 16.6% 6,940 5,060 37.1% EBIT 3,525 2,909 21.2% 619 353 75.6% EBIT margin 14.5% 13.9% 8.9% 7.0% PAT 2,538 1,833 38.5% 650 133 387.9% PAT margin 10.4% 8.8% 9.4% 2.6% PATMI 1,522 1,147 32.7% 431 127 240.3
Slide 5: 4Q Revenue Growth Trend
4Q Revenue Growth Trend • 5 Year CAGR of 9% 5 Yr CAGR: 9% 8,000 40% 6,940 7,000 37% 30% 6,006 6,000 5,618 5,040 5,060 20% 5,000 4,615 11% LKR m 9% 4,000 10% 12% 7% 3,000 0% 2,000 -10% 1,000 -16% - -20% 4QFY16 4QFY17 4QFY18 4QFY19 4QFY20 4QFY21 Revenue Revenue Growth
Slide 6: 4Q Profitability
4Q Profitability 700 650 10% 9% 600 8% 500 6% 400 6% 4% 281 4% LKR m 300 3% 169 166 3% 200 133 2% 100 0% - (100) -2% -2% (200) (139) -4% 4QFY16 4QFY17 4QFY18 4QFY19 4QFY20 4QFY21 PAT PAT Margin • Net profit of 650m compared to 133m 4Q last year due to: • Better performance in core sectors – Healthca
Slide 7: Segment Performance
Segment Performance
Slide 8: Healthcare
Healthcare Growth 4Q Growth LKR m FY21 FY20 % FY21 4Q FY20 % Revenue 12,770 11,150 14.5% 3,689 2,973 24.0% EBIT 1,197 859 39.4% 273 161 69.4% EBIT margin 9.4% 7.7% 7.4% 5.4% PAT 824 510 61.6% 231 103 124.2% PAT margin 6.4% 4.6% 6.3% 3.5% Highlights • 4QFY21 Revenue up by 24.0% YoY due to higher sale
Slide 9: Retail
Retail 13 Outlets in Colombo, and 1 online store Highlights • 4QFY21 revenue had increased 2.8% YoY • Improved digital platform • Loyalty engagement improvement • Improve pharma availability • Adjusting to the new normal with change in shopper buying habits
Slide 10: Consumer
Consumer Growth 4Q 4Q Growth LKR m FY21 FY20 % FY21 FY20 % Revenue 7,125 5,448 30.8% 2,187 1,239 76.5% EBIT 581 417 39.2% 161 (6) n/m EBIT margin 8.2% 7.7% 7.4% -0.4% PAT 467 297 57.2% 164 3 4637.1% PAT margin 6.6% 5.5% 7.5% 0.3% Highlights • Revenue increase 76.5% YoY due to revenue generated from
Slide 11: Agri
Agri Growth 4Q Growth LKR m FY21 FY20 % FY21 4Q FY20 % Revenue 3,934 3,839 2.5% 962 739 30.1% EBIT 1,818 1,115 63.0% 321 97 232.2% EBIT margin 46.2% 29.0% 33.4% 13.1% PAT 1,663 755 120.2% 400 40 901.6% PAT margin 42.3% 19.7% 41.6% 5.4% Highlights • Revenue increased by 30.1% YoY mainly due to increa
Slide 12: Energy
Energy Growth Growth LKR m FY21 FY20 % 4Q FY21 4Q FY20 % Revenue 440 313 40.8% 92 58 59.0% EBIT 34 93 -63.4% (125) 8 n/m EBIT margin 7.7% 29.7% -135.6% 14.0% PAT (35) (8) 319.9% (142) (38) n/m PAT margin -7.9% -2.6% -154.4% -65.1% Highlights • Revenue increased 59% due to favourable weather conditio
Slide 13: Additional data for analysts
Additional data for analysts 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q LKR m FY19 FY19 FY19 FY19 FY20 FY20 FY20 FY20 FY21 FY21 FY21 FY21 Revenue 5,575 5,294 5,768 6,006 5,210 5,327 5,280 5,010 4,786 6,164 6,449 6.940 PAT 341 443 501 -139 573 660 467 133 553 733 602 650 PATMI 190 234 274 -144 333 398 286 9
Slide 14: Outlook
Outlook
Slide 15: Outlook for 4Q FY21
Outlook for 4Q FY21 Healthcare Agri • Rupee depreciation to impact margins • Higher palm oil NSA • Low sales in Antibiotics and • Volume growth is expected to be Respiratory products stagnant due to government • Integration and further development of restrictions the pharma manufacturing • Expand th
Slide 16: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 17: Thank you
Thank you For more information, Please visit our Investor Relations page http://www.sunshineholdings.lk/investor%20relations/index.php